최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기BMC cancer, v.10, 2010년, pp.616 - 616
Wang, Chao-Jie (Division of Oncology, Department of Clinical and Experiment Medicine, University of Linkö) , Stratmann, Johannes (ping, Linkö) , Zhou, Zong-Guang (ping, Sweden) , Sun, Xiao-Feng (Division of Oncology, Department of Clinical and Experiment Medicine, University of Linkö)
BackgroundMicroRNAs (miRNAs) are endogenously expressed noncoding RNAs with important biological and pathological functions. Although several studies have shown that microRNA-31 (miR-31) is obviously up-regulated in colorectal cancer (CRC), there is no study on the functional roles of miR-31 in CRC....
Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 281 97 10.1016/S0092-8674(04)00045-5 14744438
Wszolek MF Rieger-Christ KM Kenney PA Gould JJ Silva Neto B Lavoie AK Logvinenko T Libertino JA Summerhayes IC A microRNA expression profile defining the invasive bladder tumor phenotype Urol Oncol 2009 in press 19945312
Filipowicz W Bhattacharyya SN Sonenberg N Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008 9 102 114 10.1038/nrg2290 18197166
Aurora EK Frank JS Oncomirs-microRNAs with a role in cancer Nature Reviews 2006 6 259 267 16557279
Lagos-Quintana M Rauhut R Lendeckel W TuschI T Identification of novel genes coding for small expressed RNAs Science 2001 294 853 858 10.1126/science.1064921 11679670
Wang CJ Zhou ZG Wang L Yang L Zhou B Gu J Chen HY Sun XF Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer Dis Markers 2009 26 27 34 19242066
Motoyama K Inoue H Takatsuno Y Tanaka F Mimori K Uetake H Sugihara K Mori M Over- and under-expressed microRNAs in human colorectal cancer Int J Oncol 2009 34 1069 1075 19287964
Slaby O Svoboda M Fabian P Smerdova T Knoflickova D Bednarikova M Nenutil R Vyzula R Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer Oncology 2007 72 397 402 10.1159/000113489 18196926
Bandrés E Cubedo E Agirre X Malumbres R Zárate R Ramirez N Abajo A Navarro A Moreno I Monzó M García-Foncillas J Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues Mol Cancer 2006 5 29 10.1186/1476-4598-5-29 16854228
Sarver AL French AJ Borralho PM Thayanithy V Oberg AL Silverstein KA Morlan BW Riska SM Boardman LA Cunningham JM Subramanian S Wang L Smyrk TC Rodrigues CM Thibodeau SN Steer CJ Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states BMC Cancer 2009 9 401 10.1186/1471-2407-9-401 19922656
Liu CJ Tsai MM Hung PS Kao SY Liu TY Wu KJ Chiou SH Lin SC Chang KW miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma Cancer Res 2010 70 1635 1644 10.1158/0008-5472.CAN-09-2291 20145132
Wong QW Lung RW Law PT Lai PB Chan KY To KF Wong N MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 2008 135 257 269 10.1053/j.gastro.2008.04.003 18555017
Wong TS Liu XB Wong BY Ng RW Yuen AP Wei WI Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue Clin Cancer Res 2008 14 2588 2592 10.1158/1078-0432.CCR-07-0666 18451220
Liu X Sempere LF Ouyang H Memoli VA Andrew AS Luo Y Demidenko E Korc M Shi W Preis M Dragnev KH Li H Direnzo J Bak M Freemantle SJ Kauppinen S Dmitrovsky E MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors J Clin Invest 2010 120 1298 1309 10.1172/JCI39566 20237410
Schaefer A Jung M Mollenkopf HJ Wagner I Stephan C Jentzmik F Miller K Lein M Kristiansen G Jung K Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma Int J Cancer 2010 26 1166 1176
Zhang Y Guo J Li D Xiao B Miao Y Jiang Z Zhuo H Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance Med Oncol 2010 27 685 689 10.1007/s12032-009-9269-x 19598010
Valastyan S Reinhardt F Benaich N Calogrias D Szász AM Wang ZC Brock JE Richardson AL Weinberg RA A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Cell 2009 137 1032 1046 10.1016/j.cell.2009.03.047 19524507
Creighton CJ Fountain MD Yu Z Nagaraja AK Zhu H Khan M Olokpa E Zariff A Gunaratne PH Matzuk MM Anderson ML Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers Cancer Res 2010 70 1906 1915 10.1158/0008-5472.CAN-09-3875 20179198
Si ML Zhu S Wu H Lu Z Wu F Mo YY miR-21-mediated tumor growth Oncogene 2007 26 2799 2803 10.1038/sj.onc.1210083 17072344
Gao C Zhang Z Liu W Xiao S Gu W Lu H Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer Cancer 2010 116 41 49 10.1002/cncr.24991 19890957
Bunz F Dutriaux A Lengauer C Waldman T Zhou S Brown JP Sedivy JM Kinzler KW Vogelstein B Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 1998 282 1497 1501 10.1126/science.282.5393.1497 9822382
Vindeløv LL Christensen IJ Nissen NI Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standard Cytometry 1983 3 328 331 10.1002/cyto.990030504 6839881
Petit E Milano G Lévi F Thyss A Bailleul F Schneider M Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients Cancer Res 1988 48 1676 1679 3345535
Rossi L Bonmassar E Faraoni I Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro Pharmacol Res 2007 56 248 253 10.1016/j.phrs.2007.07.001 17702597
Borralho PM Kren BT Castro RE da Silva IB Steer CJ Rodrigues CM MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells FEBS J 2009 276 6689 700 10.1111/j.1742-4658.2009.07383.x 19843160
Nicoloso MS Spizzo R Shimizu M Rossi S Calin GA MicroRNAs -the micro steering wheel of tumour metastases Nat Rev Cancer 2009 9 293 302 10.1038/nrc2619 19262572
Terranova VP Hujanen ES Loeb DM Martin GR Thornburg L Glushko V Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells Proc Natl Acad Sci USA 1986 83 465 469 10.1073/pnas.83.2.465 3455782
Takwi A Li Y The p53 Pathway Encounters the MicroRNA World Curr Genomics 2009 10 194 197 10.2174/138920209788185270 19881912
Machida YJ Machida Y Vashisht AA Wohlschlegel JA Dutta A The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1 J Biol Chem 2009 284 34179 34188 10.1074/jbc.M109.046755 19815555
Mahon PC Hirota K Semenza GL FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev 2001 15 2675 2686 10.1101/gad.924501 11641274
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.